Emmaus Life Sciences to be Delisted from Nasdaq Stock Market Following Hearing PRNewswire
TORRANCE, Calif., Sept. 10, 2019 /PRNewswire/ — Emmaus Life Sciences, Inc. (Nasdaq: EMMA), a leader in sickle cell disease treatment, announced today …
Emmaus Life Sciences to be Delisted from Nasdaq Stock Market Following Hearing PRNewswire
TORRANCE, Calif., Sept. 10, 2019 /PRNewswire/ — Emmaus Life Sciences, Inc. (Nasdaq: EMMA), a leader in sickle cell disease treatment, announced today …